Biopreservation Market Size (2025 – 2030)

The Global Biopreservation Market was valued at USD 5.44 billion in 2024 and is projected to reach a market size of USD 16.61 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 25.01%.   

LiDAR (Light Detection and Ranging) is a remote sensing method that employs laser pulses to quantify distances and construct high-resolution, three-dimensional representations of objects and environments. LiDAR emits laser beams that reflect off surfaces and are reflected to the sensor, permitting accurate depth and spatial calculations. LiDAR is commonly employed in autonomous cars, topographic mapping, urban planning, forestry, archaeology, and environmental monitoring. Its capacity to provide precise details under different conditions renders it critical for uses such as autonomous vehicles, drone mapping, and geospatial analysis.

Key Market Insights:

• The worldwide biopreservation market is witnessing tremendous growth, fueled by a growing demand for regenerative medicine, personalized medicine, and biobanking. One of the most important observations is the growing use of cryopreservation and sophisticated storage solutions to preserve the viability of biological samples, such as stem cells, tissues, and vaccines.
• The market is also seeing advances in preservation equipment and media technology, with technologies like AI-based laboratory information management systems (LIMS) and automated biobanking systems enhancing efficiency and data protection.
• Another key driver of the market is the increasing investments in biomedical research and drug discovery, especially in North America and Europe, where established healthcare infrastructures and government support fuel market growth.
• Though there is a good growth prospect, market expansion can be held back by issues like high expenses related to biopreservation devices, poor awareness in developing areas, and tight regulatory structures.

Global Biopreservation Market Drivers:

Rising healthcare spending is accelerating the global biopreservation market growth.  

As per the World Health Organization (WHO), the global expenditure on healthcare was estimated at USD 7.8 trillion in 2017 and USD 7.6 trillion in 2016. In 2017, the per capita healthcare expenditure of an individual was USD 41 in low-income economies and USD 2937 in high-income economies. Total spending on healthcare is increasing at a CAGR of 5% during the period 2019-2023, according to Deloitte. The United Kingdom government will spend USD 6.8 million on research and development of health in 2020. The growth in healthcare spending worldwide is providing a corresponding boost to the market for biopreservation. In addition, boosting spending on research and development to preserve biological samples is a major driver propelling the demand of the global biopreservation market. Biobanks and biopreservation play a central role in research infrastructures for basic, preclinical, translational, and clinical research. For example, during the pandemic, this biopreservation stores different samples to test and use for clinical purposes. With more research on these samples, researchers can find better medicines or vaccines for prevention. In addition, the governments have taken some measures to make people aware of the preservation of samples, which may enhance the growth rate of the market. The other major driver of the market is the development of regenerative medicine, which can cure and control diseases such as heart strokes and diabetes.

The increasing demand for biobanking has a significant impact on the global market.

The increasing need for biobanking plays a major role in the overall industry scenario. Biobanks are repositories established to store a range of biological samples from cells and tissues to blood, DNA, and other biomaterials to be utilized in research and diagnostics. Techniques utilized in biobanking are the foundation for the maintenance of the integrity, viability, and functionality of the samples, thus making them successful in long-term storage and usability. The increasing demand for large population studies, clinical trials, and studies involving access to ample, well-preserved samples of biological resources is setting the overall segment of biobanks globally. With this, the increasing focus on precision medicine and personalized treatment has further increased the importance of biobanks, as they provide large sets of samples that can be used to study the genomic content and biomarkers and formulate personalized treatment.

Global Biopreservation Market Restraints and Challenges:

The high costs associated with preserving biological samples are expected to restrain the global biopreservation market growth.

Lack of awareness among people about biopreservation is another factor that restricts market growth. Freezer samples in refrigerators become hot, liquid, or soft due to a deficiency of proper knowledge limiting the demand of the global biopreservation market. The global biopreservation market is greatly inhibited by the huge cost incurred in the biopreservation of biological samples, which hinders its wide usage. Further, people's unawareness regarding correct biopreservation techniques limits the growth of the market. The majority of biological samples chilled for freezing are prone to warming, liquidity, or softness due to poor handling and a lack of awareness, which causes sample integrity loss. Not only does this lower the efficacy of biopreservation, but it also prevents its demand in research and medical applications. These difficulties can be rectified by affordable techniques and awareness programs to drive the market.

Global Biopreservation Market Opportunities:

The international biopreservation market is characterized by substantial opportunities for growth through gains in regenerative medicine, personalized medicine, and the expansion of biobanking. The increasing demand for cell therapy, stem cell research, and organ transplantation is driving the demand for effective preservation methods. The expansion in the investment of biotechnology and pharmaceutical research is also creating a conducive environment for biopreservation solutions. Advances in cryopreservation, hypothermic storage, and vitrification are improving the quality and shelf life of biological samples, further increasing market potential. Additionally, the use of AI and automation in biopreservation procedures is enhancing efficiency and minimizing human errors. With growing awareness and government initiatives for biomedical research, the biopreservation market is expected to grow steadily in the next few years.

BIOPRESERVATION MARKET REPORT COVERAGE:

Global Biopreservation Market Segmentation:

Biopreservation Market Segmentation: By Product

• Equipment
• Media
• LIMS

The market for biopreservation globally is divided by product into three primary categories: equipment, media, and laboratory information management systems (LIMS). Equipment is an essential segment, including freezers, refrigerators, liquid nitrogen tanks, and consumables that provide the optimal storage conditions needed to preserve biological samples like cells, tissues, and organs. With developments in refrigeration and cryopreservation technologies, contemporary equipment is engineered to provide ultra-low temperatures, maintaining sample integrity over a long period. Media is another critical element of the biopreservation market, including chemical solutions and culture media that ensure the viability and stability of biological samples during storage and shipment. Cryoprotectants such as dimethyl sulfoxide (DMSO), glycerol, and serum-based or serum-free media are crucial in protecting against ice crystal growth and cellular injury, thus being a must-have for stem cell research, regenerative medicine, and biobanking applications. Finally, laboratory information management systems (LIMS) offer vital assistance with sample tracking, data management, and workflow automation within biopreservation facilities. Such computer-based systems assist in simplifying operations, improving regulatory compliance, and enabling traceability of stored biological material. With the addition of artificial intelligence and cloud-based technology, LIMS are becoming more advanced, allowing effective sample management in research institutions, biopharmaceutical firms, and healthcare organizations. Collectively, these three product segments constitute the foundation of the biopreservation industry, stimulating innovation and supporting the long-term sustainability of biological materials for scientific and medical progress.

Biopreservation Market Segmentation: By Application

• Regenerative Medicine
• Bio-banking
• Drug Discovery

The worldwide biopreservation market is divided by application into drug discovery, biobanking, and regenerative medicine, each being an important driver of improved healthcare and research. Regenerative medicine is a fast-emerging field that is based on the preservation of genetically modified cells, stem cells, and tissues for therapeutic use, such as tissue engineering and cell-based therapies. The growing use of personalized medicine and organ transplants has likewise increased the requirement for efficient biopreservation alternatives. Biobanking is one more major market, encompassing the gathering, storage, and management of biological samples such as plasma, blood, DNA, and tissue for research, as well as clinical use. As chronic ailments have grown with increasing prevalence and genomic investigation has widened the scope of medicine, biobanking has assumed a lot more importance in medicinal research. Drug discovery likewise relies significantly on biopreservation methods to keep cell lines, tissues, and biomolecules involved in pharmaceutical discovery and development in a viable condition. The quality of high-level biological samples recovered from storage enables preclinical analysis and screening of new drug candidates before they are shipped out for distribution. With the development in biotechnology ongoing, the increased demand for effective biopreservation solutions in all these applications should increase, triggering market growth as well as innovations.

Biopreservation Market Segmentation: By End Users

• Biobanks
• Gene banks
• Hospitals
• Others

The biopreservation market is divided globally based on end-users into biobanks, gene banks, hospitals, and other research centers, each contributing significantly to the preservation of biological material for different purposes. Biobanks are vital repositories of biological samples like blood, tissues, and stem cells, which aid in medical research, disease research, and personalized medicine. The growing emphasis on precision medicine and genomics developments has fuelled the need for biobanking services. Gene banks, however, are focused on the conservation of genetic material such as plant and animal germplasm to advance biodiversity conservation, agricultural research, and genetic studies. Gene banks play a crucial role in maintaining genetic diversity and the sustainability of future breeding schemes. Biopreservation methods are also utilized by hospitals to bank human tissues, organs, and stem cells for transplantation, regenerative medicine, and chronic patient management. Increased demand for organ transplantation and development in cell therapy has increased the demand for biopreservation, making it essential in medical institutions. Additional end users like research institutes, drug companies, and universities further increase the market size with the use of biopreservation solutions in drug discovery, clinical trials, and disease modeling. With ongoing technological improvements in storage methods and increasing viability of the samples, demand for biopreservation by different end users is anticipated to increase tremendously.

Biopreservation Market Segmentation: Regional Analysis:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Global biopreservation is regionally divided, with North America dominating the market with a 38% share of the total. Dominance in the region is spurred by the advanced healthcare infrastructure presence, high level of research activity in regenerative medicine, and high number of biobanking facilities. The United States contributes significantly towards market growth in terms of biotechnology and pharma research investment. Europe is next with a 28% market share, driven by robust government funding, well-established biobanks, and emerging research in personalized medicine. Nations such as Germany, the UK, and France make major contributions to biopreservation innovations. The Asia-Pacific region has a 23% share, with strong growth due to rising investments in biotechnology, increasing biobanking programs, and an emerging emphasis on stem cell research in nations such as China, Japan, and India. Expansion in the region is also driven by enhancing healthcare infrastructure and awareness of the uses of biopreservation. South America accounts for 6% of the market with expanding research activities and enhancing investments in medical biotechnology, especially in nations such as Brazil and Argentina. The market expansion remains a little slow compared to other regions. Middle East & Africa, with a 5% market share, is the smallest segment, mostly owing to scarce infrastructure and weaker uptake of high-end biopreservation technologies. Increasing healthcare facilities and government efforts in nations such as South Africa and the UAE are anticipated to drive future market growth. Generally, though North America and Europe continue to lead, Asia-Pacific is a rising market with high-growth potential, fueled by advancing technology and growing research efforts.

COVID-19 Impact Analysis on the Global Biopreservation Market:

The COVID-19 pandemic greatly influenced the global biopreservation market, creating both challenges and opportunities. The rise in demand for biopreservation solutions accelerated as research institutions, pharmaceutical firms, and healthcare organizations increased efforts to create vaccines, research the virus, and preserve biological samples for future use. The demand for efficient cryopreservation methods increased, especially for vaccine storage and transport, and this led to the development of ultra-low temperature freezers and liquid nitrogen storage systems. Biobanks also contributed significantly to the collection and storage of COVID-19 samples for drug development and epidemiological research. The pandemic also disrupted supply chains, resulting in delays in equipment production and raw material shortages, temporarily slowing market growth. Despite such challenges, the increased emphasis on biomedical research, regenerative medicine, and vaccine manufacturing has fortified the biopreservation sector, guaranteeing long-term market growth and technological innovation.

Latest Trends/ Developments:

The global biopreservation market is also experiencing several recent trends and innovations, fuelled by emerging biotechnology, automation, and personalized medicine. One of them is the incorporation of artificial intelligence (AI) and automation in sample handling and biobanking, enhancing accuracy, efficiency, and traceability. The growing use of cloud-based laboratory information management systems (LIMS) is optimizing data storage and retrieval processes and improving regulatory compliance. Another key advancement is the emergence of cryopreservation methods, especially for regenerative medicine and cell-based treatments, to guarantee the long-term preservation of biological specimens. Furthermore, the need for environmentally friendly and energy-saving preservation devices is increasing as companies seek to minimize their carbon footprint. The growth in stem cell research and gene therapy treatments is also driving development in preservation media and cryoprotectants. Additionally, the industry is witnessing growth in private investments and government funding toward biobanking and precision medicine, speeding up R&D activity. With emerging technologies and increased healthcare applications, the market for biopreservation is ready for continued expansion and development.

 Key Players:

1. Thermo Fisher Scientific Inc.
2. BioLife Solutions Inc.
3. BioCision LLC
4. Panasonic Corporation
5. VWR International LLC
6. Sigma-Aldrich Corporation
7. Taylor-Wharton
8. Cesca Therapeutics
9. Lifeline Scientific Inc.